New research commissioned by Milton Park reveals that £2.14 billion of equity investment was generated across 272 companies based in the science, technology and business community over the past decade.
The arrival of G7 health ministers to Oxford on Thursday 03 June will shine a spotlight on Oxfordshire’s considerable achievements in the life sciences sector.
Led by an existing investor, the funding follows positive Phase 3 trial interim analysis data for tebentafusp in patients with metastatic uveal melanoma.